D1 Capital Partners
SuperinvestorD1 Capital Partners L.P.
- SEC CIK
- 0001747057
- Manager
- Dan Sundheim
- Style
- Growth, Hedge fund
- Latest filing
- Aug 14, 2026
The latest 13F from D1 Capital Partners covers Q2 2026 (filed Aug 14, 2026): 55 long positions worth $34.8B. The top 10 holdings make up 76.7% of the portfolio, and the largest is Space Exploration Technologies Corp (SPCX) at 61.9%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Full comparisonShare counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 21
- Est. +$23.8B
- Added
- 16
- Est. +$1.51B
- Reduced
- 16
- Est. −$1.46B
- Sold out
- 10
- Est. −$1.67B
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $34.8B
- +$23.6B (+209.7%) vs. prior quarter
- Positions
- 55
- +11 vs. prior quarter
- Top 10 concentration
- 76.7%
- Top 10 as share of value
- Turnover
- 13.6%
- Q2 2026, one quarter
- Average holding period
- 2.2 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $34.8B (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 55 | $34.8B | SPCXCARTJHX | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 44 | $11.2B | CARTMELIJHX | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 42 | $10.7B | CARTCLHFLS | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 38 | $8.71B | CARTAPPCLH | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 33 | $7.20B | CARTXPOBAC | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 41 | $6.53B | CARTENTGSCHW | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 35 | $6.02B | CARTPMRCL | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 34 | $5.18B | CARTXPOPM | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 35 | $5.93B | CARTPMLEN | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 34 | $6.58B | CARTPMVMRK | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 28 | $5.69B | CARTPMMETA | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 37 | $6.94B | CARTMSFTMETA | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 38 | $5.20B | SGIMSFTELV | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 35 | $5.31B | MSFTELVGOOGL | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 30 | $4.88B | MSFTAMZNRH | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 33 | $5.48B | MSFTAMZNRIVN | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 24 | $4.22B | MSFTEXPEAMZN | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 25 | $8.49B | EXPEMSFTRIVN | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 45 | $16.6B | EXPERIVNCVNA | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 66 | $17.9B | EXPEJDHOOD | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 56 | $15.3B | JDEXPEAMZN | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 47 | $13.5B | MSFTJDEXPE | – | SEC |
13D and 13G filings
Companies where D1 Capital Partners reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
1 company, largest stake first.
Latest filings
70 filings on file made by D1 Capital Partners or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| PURRHyperliquid Strategies Inc | Aug 14, 202611:00 AM ET | 13G/A | 3.20%6.34M shares | −3.10 ppfrom 6.30%Below 5% | Jun 30, 2026 | SEC |
| CLHClean Harbors Inc | May 15, 202612:58 PM ET | 13G/A | 2.50%1.34M shares | −2.70 ppfrom 5.20%Below 5% | Mar 31, 2026 | SEC |
| KRCKilroy Realty Corp | May 15, 202612:38 PM ET | 13G/A | 9.50%11.3M shares | +0.70 ppfrom 8.80% | Mar 31, 2026 | SEC |
| FLSFlowserve Corp | May 15, 202612:04 PM ET | 13G/A | 4.60%5.87M shares | −1.10 ppfrom 5.70%Below 5% | Mar 31, 2026 | SEC |
| PURRHyperliquid Strategies Inc | Feb 17, 202612:09 PM ET | 13G | 6.30%8.00M shares | New | Dec 31, 2025 | SEC |
| CLHClean Harbors Inc | Feb 17, 202612:08 PM ET | 13G | 5.20%2.78M shares | New | Dec 31, 2025 | SEC |
| KRCKilroy Realty Corp | Feb 17, 202612:03 PM ET | 13G/A | 8.80%10.4M shares | +1.60 ppfrom 7.20% | Dec 31, 2025 | SEC |
| FLSFlowserve Corp | Nov 14, 20252:37 PM ET | 13G | 5.70%7.48M shares | New | Sep 30, 2025 | SEC |
| KRCKilroy Realty Corp | Nov 14, 20252:33 PM ET | 13G | 7.20%8.48M shares | New | Sep 30, 2025 | SEC |
| LXEOLexeo Therapeutics, Inc. | May 15, 20259:58 AM ET | 13G/A | 2.90%978.7K shares | –Below 5% | Mar 31, 2025 | SEC |
| WRBYWarby Parker Inc. | May 7, 20259:00 AM ET | 13G/A | 0.00%0 shares | −5.20 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| WRBYWarby Parker Inc. | Feb 14, 202510:01 AM ET | 13G/A | 5.20%5.29M shares | – | Dec 31, 2024 | SEC |
| CARTMaplebear Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| WRBYWarby Parker Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| WRBYWarby Parker Inc. | Jul 10, 2024 | 13G/AOld format | – | – | – | SEC |
| LXEOLexeo Therapeutics, Inc. | Feb 14, 2024 | 13GOld format | – | New | – | SEC |
| RHRH | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| CARTMaplebear Inc. | Feb 14, 2024 | 13GOld format | – | New | – | SEC |
| SGHTSight Sciences, Inc. | Jan 10, 2024 | 13G/AOld format | – | – | – | SEC |
| Cazoo Group Ltd | Nov 13, 2023 | 13D/AOld format | – | – | – | SEC |